|
CTBP2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.572240E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.509570E-01 |
| Normal-vs-Stage2 |
9.910600E-01 |
| Normal-vs-Stage3 |
5.357800E-01 |
| Normal-vs-Stage4 |
7.293200E-01 |
| Stage1-vs-Stage2 |
4.819800E-01 |
| Stage1-vs-Stage3 |
1.809580E-01 |
| Stage1-vs-Stage4 |
7.776000E-01 |
| Stage2-vs-Stage3 |
6.522800E-01 |
| Stage2-vs-Stage4 |
7.869000E-01 |
| Stage3-vs-Stage4 |
5.313800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.809800E-01 |
| Normal-vs-AfricanAmerican |
1.495970E-01 |
| Normal-vs-Asian |
2.288200E-01 |
| Caucasian-vs-AfricanAmerican |
5.530200E-01 |
| Caucasian-vs-Asian |
1.518160E-01 |
| AfricanAmerican-vs-Asian |
5.773800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.756200E-01 |
| Normal-vs-Female |
3.566600E-01 |
| Male-vs-Female |
9.537200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.893000E-01 |
| Normal-vs-Extreme_Weight |
4.637000E-01 |
| Normal-vs-Obese |
8.331900E-02 |
| Normal-vs-Extreme_Obese |
8.308800E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.064800E-01 |
| Normal_Weight-vs-Obese |
4.066100E-02 |
| Normal_Weight-vs-Extreme_Obese |
7.916200E-01 |
| Extreme_Weight-vs-Obese |
3.723000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.411000E-01 |
| Obese-vs-Extreme_Obese |
3.349600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.776810E-01 |
| Normal-vs-Age(41-60Yrs) |
6.498100E-03 |
| Normal-vs-Age(61-80Yrs) |
9.151800E-01 |
| Normal-vs-Age(81-100Yrs) |
1.700960E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.709200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.861380E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.247500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.943800E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.294250E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.433440E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.604300E-04 |
| Normal-VS-Type2 PRCC |
8.600100E-04 |
| Normal-VS-KIRP CIMP |
1.320200E-01 |
| Normal-VS-Unclassified PRCC |
3.457600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.73160000069583E-09 |
| Type1 PRCC-VS-KIRP CIMP |
8.725000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.681000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.417900E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.563430E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
4.607800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.068580E-01 |
| Normal-vs-N1 |
8.489200E-01 |
| Normal-vs-N2 |
7.620800E-01 |
| N0-vs-N1 |
3.406200E-01 |
| N0-vs-N2 |
9.428600E-01 |
| N1-vs-N2 |
7.254800E-01 |
|
|
